» Articles » PMID: 30898570

Oxysterol Modulates Neurotransmission Via Liver-X Receptor/NO Synthase-dependent Pathway at the Mouse Neuromuscular Junctions

Overview
Specialties Neurology
Pharmacology
Date 2019 Mar 23
PMID 30898570
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Elimination of brain cholesterol occurs in the form of 24S-hydroxycholesterol (24S-HCh) that may modulate physiological processes outside the brain. Here, using microelectrode recording of postsynaptic responses (end-plate potentials, EPPs) and fluorescent marker (FM1-43) for endo-exocytosis we studied the effects of prolonged application of 24S-HCh (2.5 h, 0.4 μM) on the neurotransmission in the mice diaphragm. 24S-HCh enhanced the depression of EPP amplitude (indicator of neurotransmitter release) and suppressed the FM1-43 dye unloading from nerve terminals (indicator of exocytosis) during electrical nerve stimulation at 20 Hz, without affecting miniature EPP amplitude and frequency. Comparison of the rates of neurotransmitter and FM1-43 releases suggested an increase in time required for the synaptic vesicle reuse. Additionally, 24S-HCh potentiated an increase in DAF-FM fluorescence (a NO-sensitive marker) in response to 20 Hz stimulation. All effects of 24S-HCh were completely prevented by liver X receptor antagonist. Either inhibitors of NO synthases (TRIM, cavtratin) or protein synthesis blocker counteracted the 24S-HCh-mediated enhancement in DAF-FM fluorescence, while inhibition of NO production with l-NAME or cavtratin and extracellular NO chelation suppressed the effect of 24S-HCh on FM1-43 dye loss during 20 Hz activity. Pretreatment for 5 days with inhibitor of 24S-HCh synthesis (voriconazole) had opposite effects on the FM1-43 unloading and NO synthesis. These data suggest that prolonged exposure to 24S-HCh attenuates recruitment of synaptic vesicle to exocytosis during 20 Hz stimulation acting via liver Х receptor/NO-dependent signaling.

Citing Articles

25-Hydroxycholesterol modulates synaptic vesicle endocytosis at the mouse neuromuscular junction.

Kuznetsova E, Zakirjanova G, Tsentsevitsky A, Petrov A Pflugers Arch. 2025; 477(3):421-439.

PMID: 39786596 DOI: 10.1007/s00424-024-03058-0.


24S-Hydroxycholesterol in Neuropsychiatric Diseases: Schizophrenia, Autism Spectrum Disorder, and Bipolar Disorder.

Messedi M, Makni-Ayadi F Adv Exp Med Biol. 2023; 1440:293-304.

PMID: 38036886 DOI: 10.1007/978-3-031-43883-7_15.


Oxysterols in Central and Peripheral Synaptic Communication.

Petrov A Adv Exp Med Biol. 2023; 1440:91-123.

PMID: 38036877 DOI: 10.1007/978-3-031-43883-7_6.


25-Hydroxycholesterol as a Signaling Molecule of the Nervous System.

Odnoshivkina U, Kuznetsova E, Petrov A Biochemistry (Mosc). 2022; 87(6):524-537.

PMID: 35790411 PMC: 9201265. DOI: 10.1134/S0006297922060049.


Effects of Oxysterols on Immune Cells and Related Diseases.

de Freitas F, Levy D, Reichert C, Cunha-Neto E, Kalil J, Bydlowski S Cells. 2022; 11(8).

PMID: 35455931 PMC: 9031443. DOI: 10.3390/cells11081251.